The synergistic effect of BKM120 and HCQ combination in PIK3CA-mutant cancer cells is not related to the type of PIK3CA mutation and other factors seem to be involved because Caski and MCF7 with the same PIK3CA mutation (E545K) showed different responses to the combined treatment of BKM120 and HCQ. This evidence concerns the gene PIK3CA and cancer.